InnoCare Pharma Limited
InnoCare Pharma Limited has 1 licensing announcement in this dataset, dated 2026-09-24.
- Country / operating region
- China
- Ticker
- 09969.HK
- Headquarters
- 查無
- Founded
- 查無
- Business
- Drug discovery and development
- Website
- www.innocarepharma.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| Up to five discovery target programs | 查無 | 查無 | preclinical | 2026-09-24 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Eli Lilly and Company | Up to five discovery target programs | 查無 | 查無 | ≈ ≤ USD 3250m | 查無 | Combined upfront + near-term ≤ USD 100m |
| Counterparty | Territory | Royalties |
|---|---|---|
| Eli Lilly and Company | Worldwide | Single-digit tiered royalties on annual net product sales. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無